Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation

NCT03097861 is registered in ClinicalTrials.gov with Sucampo Pharma Americas, LLC as lead sponsor.

NCT NCT03097861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03097861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation
Lead sponsor
Sucampo Pharma Americas, LLC
Phase
Phase 3
Overall status
Completed
Start date
March 13, 2017
Completion date
August 17, 2017
Enrollment
552 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic constipation